Holdings of JOHNSON & JOHNSON
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 14 in 3 countries
- Top ten
- 99.5 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc | 2,449,183 | 258.1M $ | |
| 2 | NANOBIOTIX SA | 5,623,816 | 173.6M $ | |
| 3 | Rapport Therapeutics Inc | 1,784,517 | 55.8M $ | |
| 4 | CVRx Inc | 4,024,861 | 38.1M $ | |
| 5 | Contineum Therapeutics Inc | 1,979,173 | 25.8M $ | |
| 6 | LEGEND BIOTECH CORP | 814,586 | 14.7M $ | |
| 7 | Xencor Inc | 748,062 | 9M $ | |
| 8 | PROCEPT BIOROBOTICS CORP | 357,939 | 9M $ | |
| 9 | Fate Therapeutics Inc | 3,379,064 | 4.1M $ | |
| 10 | Neumora Therapeutics Inc | 1,849,445 | 3.6M $ | |
| 11 | RALLYBIO CORP | 152,901 | 1.4M $ | |
| 12 | Vor BioPharma Inc | 53,732 | 958.6K $ | |
| 13 | Standard BioTools Inc | 311,967 | 286.8K $ | |
| 14 | Adicet Bio Inc | 22,779 | 155.1K $ |
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 68.3 %
- France 29.2 %
- Cayman Islands 2.5 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 12 | 406.3M $ | 68.33 % |
| 2 | France | 1 | 173.6M $ | 29.19 % |
| 3 | Cayman Islands | 1 | 14.7M $ | 2.48 % |
Cite this page
Titelia. "Holdings of JOHNSON & JOHNSON". https://titelia.com/en/funds/US13F200406